T 0251/25 of 29.06.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T025125.20260629
- Date of decision
- 29 June 2026
- Case number
- T 0251/25
- Online on
- 29 September 2026
- Petition for review of
- -
- Application number
- 14715274.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Therapeutic uses of empagliflozin
- Applicant name
- Boehringer Ingelheim International GmbH
- Opponent name
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
SANDOZ AG
Zentiva k.s.
STADA Arzneimittel AG
Sanovel IIaç San. ve Tic. A.S
Adalvo Ltd.
Aera A/S
HGF Limited
Generics (U.K.) Limited
Dr Reddy's Laboratories (UK) Limited - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83
- Keywords
- Sufficiency of disclosure - (no)
- Catchword
- -
- Cited cases
- G 0001/03G 0002/08G 0002/21R 0025/22R 0014/23T 0019/90T 0241/95T 0158/96T 0609/02T 0063/06T 1558/11T 0294/20T 0853/22T 0583/23
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.